c-Jun N-terminal kinase is upregulated in patients with hypospadias.

Urology

Department of Pediatric Urology Surgery, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing, Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.

Published: January 2013

Objective: To investigate the expression of c-Jun N-terminal kinase (JNK) 1/2 in human hypospadiac tissue compared with that in normal penile tissue.

Materials And Methods: Penile skin tissue specimens obtained at surgery during hypospadias repair or during elective circumcision were divided into 3 groups according to the position of the urethral meatus: children with mild hypospadias (n=16), severe hypospadias (n=16), and normal controls (n=16). The expression of total and phosphorylated JNK1 and JNK2 at the messenger ribonucleic acid and protein levels were assessed using real-time quantitative polymerase chain reaction, immunochemistry, and Western blot analysis.

Results: JNK1 messenger ribonucleic acid expression and JNK1 and JNK2 phosphorylated protein levels increased significantly in subjects with mild or severe hypospadias compared with the controls (P<.05). JNK2 phosphorylated protein levels increased significantly in those with severe hypospadias compared with those with mild hypospadias (P<.05). Those with hypospadias had increased phosphorylation protein expression of JNK1/2 in the mesenchymal cell layers of the preputial subcutaneous mesenchymal cell layer.

Conclusion: Our findings suggest that JNK upregulation might contribute to the development of hypospadias and might associated with mesenchymal cell migration in the process of external male genitalia defect development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.09.010DOI Listing

Publication Analysis

Top Keywords

c-jun n-terminal
8
n-terminal kinase
8
hypospadias n=16
8
severe hypospadias
8
jnk1 jnk2
8
messenger ribonucleic
8
ribonucleic acid
8
protein levels
8
hypospadias
5
kinase upregulated
4

Similar Publications

Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis.

Nat Cardiovasc Res

January 2025

Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Beyond dyslipidemia, inflammation contributes to the development of atherosclerosis. However, intrinsic factors that counteract vascular inflammation and atherosclerosis remain scarce. Here we identify insulin-like growth factor binding protein 6 (IGFBP6) as a homeostasis-associated molecule that restrains endothelial inflammation and atherosclerosis.

View Article and Find Full Text PDF

Cys44 of SARS-CoV-2 3CL affects its catalytic activity.

Int J Biol Macromol

January 2025

Department of Chemical Sciences, University of Naples "Federico II", Via Cintia, 21, 80126 Napoli, Italy; CEINGE Advanced Biotechnologies s.c.a r.l. "Franco Salvatore", Via Gaetano Salvatore 486, 80131 Napoli, Italy. Electronic address:

SARS-CoV-2 encodes a 3C-like protease (3CL) that is essential for viral replication. This cysteine protease cleaves viral polyproteins to release functional nonstructural proteins, making it a prime target for antiviral drug development. We investigated the inhibitory effects of halicin, a known c-Jun N-terminal kinase inhibitor, on 3CL.

View Article and Find Full Text PDF

CBD and the 5-HT1A receptor: A medicinal and pharmacological review.

Biochem Pharmacol

January 2025

Department of Biomedical Sciences, College of Medicine, University of Houton, Houston, TX, 77204, USA. Electronic address:

Cannabidiol (CBD), a phytocannabinoid, has emerged as a promising candidate for addressing a wide array of symptoms. It has the ability to bind multiple proteins and receptors, including 5-HT1AR, transient receptor potential vanilloid 1 (TRPV1), and cannabinoid receptors. However, CBD's pharmacodynamic interaction with 5-HT1AR and its medicinal outcomes are still debated.

View Article and Find Full Text PDF

Hinokitiol (HK), a monoterpenoid that naturally occurs in plants belonging to the Cupressaceae family, possesses important biological activities, including an anticancer effect. This review summarizes its anticancer potential and draws possible molecular interventions. In addition, it evaluates the biopharmaceutical, toxicological properties, and clinical application of HK to establish its viability for future advancement as a dependable anticancer medication.

View Article and Find Full Text PDF

A Combined Extract from and Mitigates PM-Induced Respiratory Damage by NF-κB/TGF-β1 Pathway.

Antioxidants (Basel)

December 2024

Division of Applied Life Science (BK21), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Republic of Korea.

This research evaluated the protective role of a combined extract of and (DBZO) against respiratory dysfunction caused by particulate matter (PM) exposure in BALB/c mice. The bioactive compounds identified in the DBZO are catechin, astragalin, 6-gingerol, 8-gingerol, and 6-shogaol. DBZO ameliorated cell viability and reactive oxygen species (ROS) production in PM-stimulated A549 and RPMI 2650 cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!